chr19-11576317-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_001611.5(ACP5):​c.661G>A​(p.Val221Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00645 in 1,611,542 control chromosomes in the GnomAD database, including 612 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V221V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.035 ( 313 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 299 hom. )

Consequence

ACP5
NM_001611.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.26

Publications

4 publications found
Variant links:
Genes affected
ACP5 (HGNC:124): (acid phosphatase 5, tartrate resistant) This gene encodes an iron containing glycoprotein which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. [provided by RefSeq, Aug 2008]
ZNF627 (HGNC:30570): (zinc finger protein 627) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 7 uncertain in NM_001611.5
BP4
Computational evidence support a benign effect (MetaRNN=0.002044946).
BP6
Variant 19-11576317-C-T is Benign according to our data. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11576317-C-T is described in CliVar as Benign. Clinvar id is 464890.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACP5NM_001611.5 linkc.661G>A p.Val221Ile missense_variant Exon 4 of 5 ENST00000648477.1 NP_001602.1 P13686A0A024R7F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACP5ENST00000648477.1 linkc.661G>A p.Val221Ile missense_variant Exon 4 of 5 NM_001611.5 ENSP00000496973.1 P13686

Frequencies

GnomAD3 genomes
AF:
0.0354
AC:
5384
AN:
152100
Hom.:
312
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00976
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.00931
AC:
2313
AN:
248382
AF XY:
0.00688
show subpopulations
Gnomad AFR exome
AF:
0.131
Gnomad AMR exome
AF:
0.00484
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.00246
GnomAD4 exome
AF:
0.00343
AC:
5012
AN:
1459324
Hom.:
299
Cov.:
33
AF XY:
0.00289
AC XY:
2096
AN XY:
725980
show subpopulations
African (AFR)
AF:
0.127
AC:
4260
AN:
33460
American (AMR)
AF:
0.00575
AC:
257
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51430
Middle Eastern (MID)
AF:
0.00327
AC:
18
AN:
5512
European-Non Finnish (NFE)
AF:
0.0000405
AC:
45
AN:
1111870
Other (OTH)
AF:
0.00691
AC:
417
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
255
510
766
1021
1276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0354
AC:
5389
AN:
152218
Hom.:
313
Cov.:
32
AF XY:
0.0349
AC XY:
2596
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.125
AC:
5172
AN:
41508
American (AMR)
AF:
0.00975
AC:
149
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000250
AC:
17
AN:
68026
Other (OTH)
AF:
0.0218
AC:
46
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
219
439
658
878
1097
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0130
Hom.:
225
Bravo
AF:
0.0407
ESP6500AA
AF:
0.128
AC:
566
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0119
AC:
1443
Asia WGS
AF:
0.00722
AC:
26
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Spondyloenchondrodysplasia with immune dysregulation Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
19
DANN
Benign
0.93
DEOGEN2
Benign
0.27
T;T;T;T;T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.50
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Uncertain
0.88
.;.;.;.;D
MetaRNN
Benign
0.0020
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L;L;L;L;L
PhyloP100
2.3
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.44
.;N;N;.;N
REVEL
Benign
0.20
Sift
Benign
0.21
.;T;T;.;T
Sift4G
Benign
0.33
.;T;T;T;T
Polyphen
0.078
B;B;B;B;B
Vest4
0.095, 0.094
MPC
0.36
ClinPred
0.0037
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.15
gMVP
0.47
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229532; hg19: chr19-11687132; COSMIC: COSV54536780; COSMIC: COSV54536780; API